Alyeska Investment Group, L.P. Novartis Ag Transaction History

Alyeska Investment Group, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $70 Million - $79.7 Million	-735,078 Reduced 97.31%	20,321 $1.97 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $69.7 Million - $76.7 Million	755,399 New	755,399 $76.3 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $9.07 Million - $10.3 Million	107,486 Added 20.43%	633,696 $60 Million
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $3.7 Million - $4.08 Million	-43,240 Reduced 7.59%	526,210 $45.7 Million
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $492,512 - $606,169	-6,532 Reduced 1.13%	569,450 $0
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $3.6 Million - $4.12 Million	-47,777 Reduced 7.66%	575,982 $0
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $12 Million - $13.3 Million	-162,542 Reduced 20.67%	623,759 $53.5 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $52.6 Million - $60.9 Million	786,301 New	786,301 $67.7 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.